Stocks Settle Higher as Magnificent Seven Stocks Climb
Stocks extended Monday's sharp gains in hopes that next week's upcoming US reciprocal tariffs would be more targeted than previously stated and narrower than initially planned, with Mr. Trump saying, ...
First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for ImmutepGlobal Phase III with ...
Stocks Extend Monday's Gains as Trade Concerns Subside
Stock indexes are moderately higher today on carryover support from Monday's sharp gains in hopes that next week's upcoming US reciprocal tariffs would be more targeted than previously stated and ...
Immuneering Corporation Announces Grant of Inducement Award
Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The Company’s lead product candidate, IMM-1-104 ...